Lisinopril pediatric use
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril Pediatric Use: Indications and Clinical Applications
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly used in children for the treatment of hypertension, heart failure, and nephroprotection, including after kidney transplantation and in specific renal diseases such as IgA nephropathy 2357. Its use in pediatric patients is often off-label, especially in those under 6 years of age 49.
Dosing, Efficacy, and Safety in Pediatric Hypertension
Studies show that lisinopril is effective in reducing blood pressure in children with hypertension. Typical starting doses are around 0.1 mg/kg/day, with dose adjustments based on clinical response and tolerability 356. In controlled and real-world settings, lisinopril has demonstrated significant reductions in both systolic and diastolic blood pressure, with most patients achieving target blood pressure within months of therapy initiation 2369. However, efficacy may decline after 2–3 years, especially in children with abnormal kidney function, indicating the need for ongoing dose recalibration or alternative therapies .
Use in Pediatric Kidney Disease and Transplantation
Lisinopril is frequently used for nephroprotection in children with chronic kidney disease (CKD) and after kidney transplantation. It helps reduce proteinuria and control blood pressure, with studies showing a steady response in CKD patients and improved diastolic control over extended periods 257. In children with mild IgA nephropathy, lisinopril significantly reduced proteinuria and was well tolerated over two years . In pediatric kidney transplant recipients, lisinopril was effective and well tolerated, with dosing adjusted according to kidney function .
Pharmacokinetics and Formulation Considerations
Pharmacokinetic studies indicate that lisinopril clearance in children is influenced by age and kidney function, but exposure at standard doses is within expected ranges for both healthy children and those with kidney transplants 458. For children who have difficulty swallowing tablets, a liquid formulation or suspension can be used, and research into nanocapsule-based oral formulations may further improve administration in pediatric populations 18.
Safety Profile and Adverse Events
Lisinopril is generally well tolerated in children, with hypotension being the most common adverse event, occurring in a small percentage of patients 3610. Other side effects, such as dizziness, may require dose adjustment but rarely necessitate discontinuation . Laboratory profiles, including hematology and serum biochemistry, are typically unaffected, and growth is not impaired during long-term use . In cases of accidental ingestion, doses up to 4 mg/kg or 40 mg total in children over 9 months of age are unlikely to cause significant toxicity and can often be managed at home .
Special Populations: Post-Cardiothoracic Surgery and Young Children
Lisinopril has been shown to be safe and effective for controlling hypertension in children under 7 years of age following cardiothoracic surgery, especially when converting from captopril using a 3:1 dose ratio . This expands its potential use in younger pediatric patients, despite formal approval being limited to older children in some regions 49.
Conclusion
Lisinopril is a well-studied and effective option for managing pediatric hypertension and kidney-related conditions. It is generally safe, with a favorable side effect profile and flexible dosing that can be tailored to individual patient needs. Ongoing research into new formulations and long-term outcomes will continue to improve its utility in pediatric care 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic